Enteral Feeding Formula Market Report 2026

Enteral Feeding Formula Market Report 2026
Global Outlook – By Product (Standard Formulas, Disease-Specific Formulas), By Stage (Adults, Pediatrics), By Application (Oncology, Gastroenterology, Neurology, Diabetes, Critical Care, Other Applications), By End User (Hospitals, Long-Term Care Facilities) – Market Size, Trends, Strategies, and Forecast to 2035
Enteral Feeding Formula Market Overview
• Enteral Feeding Formula market size has reached to $7.09 billion in 2025 • Expected to grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Surging Demand For Home Care Services Drives Growth Of Enteral Feeding Formula Market • Market Trend: The Rise Of Advanced Feeding Pumps • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Enteral Feeding Formula Market?
The enteral feeding formulas are food formulations containing specific nutrients as per the need of the consumer. Patients who are in intensive care or are unable to swallow the food need certain nutrients. The enteral feeding formulations can fulfil the nutrients and nutritional requirements. They are used for directly delivering the food or nutrients to the patient’s stomach or small intestine. The main products of enteral feeding formulas are standard formulas and disease-specific formulas. Standard feeding formulas are formulas intended for people with normal digestion. Standard formulas consist of all the nutrients that are required to maintain health. The stages are adults and pediatrics. The applications of enteral feeding formulas are oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Hospitals and long-term care facilities are the end users of enteral feeding formulas.
What Is The Enteral Feeding Formula Market Size and Share 2026?
The enteral feeding formula market size has grown rapidly in recent years. It will grow from $7.09 billion in 2025 to $7.81 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increasing icu admissions, rising prevalence of chronic diseases, growth in aging population, expansion of hospital infrastructure, higher awareness of clinical nutrition.What Is The Enteral Feeding Formula Market Growth Forecast?
The enteral feeding formula market size is expected to see rapid growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growth in home healthcare nutrition, increasing cancer and neurological disorder cases, rising demand for personalized nutrition, technological advances in feeding tubes and pumps, expanding healthcare access in emerging economies. Major trends in the forecast period include rising demand for disease-specific enteral formulas, increasing use of high-protein and specialized nutrition, growth in pediatric enteral nutrition adoption, expanding use of enteral feeding in home care settings, innovation in taste, texture, and tolerance improvement.Global Enteral Feeding Formula Market Segmentation
1) By Product: Standard Formulas, Disease-Specific Formulas 2) By Stage: Adults, Pediatrics 3) By Application: Oncology, Gastroenterology, Neurology, Diabetes, Critical Care, Other Applications 4) By End User: Hospitals, Long-Term Care Facilities Subsegments: 1) By Standard Formulas: Polymer-Based Formulas, Oligomeric Formulas, High-Protein Formulas 2) By Disease-Specific Formulas: Diabetic Formulas, Renal Formulas, Pulmonary Formulas, Oncology FormulasWhat Is The Driver Of The Enteral Feeding Formula Market?
Increasing demand for home care services is expected to propel the market for enteral feeding formulas going forward. Home care services refer to a wide range of supportive services for individuals who need assistance with daily activities but wish to remain in the comfort of their own homes. Enteral feeding is increasingly used in home-based care for patients who require long-term nutritional support. For instance, in November 2024, according to the U.S. Bureau of Labor Statistics, a U.S.-based federal agency, in May 2023, New York had 60 home health and personal care aide jobs per 1,000, which was 2.5 times higher than the national average of 24 per 1,000. Therefore, increasing demand for home care services will drive the growth of the enteral feeding formula industry.Key Players In The Global Enteral Feeding Formula Market
Major companies operating in the enteral feeding formula market are Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, B. Braun Melsungen AG, Meiji Holdings Co. Ltd., Real Food Blends, Ajinomoto Cambrooke Inc., Otsuka Pharmaceutical Co. Ltd., Medtrition Inc., Nutri-Force Nutrition, Global Health Product Inc., VICTUS, Kate Farms, Baxter International Inc., Perrigo Nutritionals LLC, Reckitt Benckiser Group plc, Bio-Serv Inc., Nutrabalace Ltd., Med-Diet Laboratories Inc., Precision Foods-Kent Corporation, SimplyThick LLC, Vitaflow LLCGlobal Enteral Feeding Formula Market Trends and Insights
Major companies operating in the enteral feeding formulas market are developing technologically advanced products, such as enteral feeding pumps to enhance their product offerings. An enteral feeding pump is a medical device used to deliver liquid nutrition directly into a patient's stomach or intestines through a feeding tube, ensuring precise and controlled nutrient administration for individuals who cannot eat by mouth. For instance, in September 2023, Cardinal Health, a US-based healthcare company, launched the Kangaroo OMNI enteral feeding pump. It is designed to provide enteral feeding patients with enhanced options tailored to their personalized needs, featuring portability and versatility to deliver thick formulas and hydration across various care settings. It offers enhanced water resistance, allowing it to be cleaned under running water, and comes with compatible accessories like a pole clamp and table stand. Additionally, the pump can display screen content in 19 different languages.What Are Latest Mergers And Acquisitions In The Enteral Feeding Formula Market?
In May 2024, Danone, a France-based food and beverage company, acquired Functional Formularies for an undisclosed amount. As a result of the acquisition, Danone is set to enhance its offerings for individuals with special medical needs, particularly in the enteral tube-feeding segment. With the addition of Functional Formularies' highly differentiated product portfolio, which complements Danone's existing Real Food Blends range, the company is now better positioned to support the nutritional needs of tube-fed patients and their families. Functional Formularies is a US-based provider of enteral feeding formulas.Regional Insights
North America was the largest region in the enteral feeding formula market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Enteral Feeding Formula Market?
The enteral feeding formulas consists of sales of diabetic formula, renal formula, hepatic formula, pulmonary formula and peptide-based formula. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Enteral Feeding Formula Market Report 2026?
The enteral feeding formula market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the enteral feeding formula industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Enteral Feeding Formula Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.81 billion |
| Revenue Forecast In 2035 | $11.52 billion |
| Growth Rate | CAGR of 10.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Stage, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, B. Braun Melsungen AG, Meiji Holdings Co. Ltd., Real Food Blends, Ajinomoto Cambrooke Inc., Otsuka Pharmaceutical Co. Ltd., Medtrition Inc., Nutri-Force Nutrition, Global Health Product Inc., VICTUS, Kate Farms, Baxter International Inc., Perrigo Nutritionals LLC, Reckitt Benckiser Group plc, Bio-Serv Inc., Nutrabalace Ltd., Med-Diet Laboratories Inc., Precision Foods-Kent Corporation, SimplyThick LLC, Vitaflow LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Enteral Feeding Formula market was valued at $7.09 billion in 2025, increased to $7.81 billion in 2026, and is projected to reach $11.52 billion by 2030.
request a sample hereThe global Enteral Feeding Formula market is expected to grow at a CAGR of 10.2% from 2026 to 2035 to reach $11.52 billion by 2035.
request a sample hereSome Key Players in the Enteral Feeding Formula market Include, Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, B. Braun Melsungen AG, Meiji Holdings Co. Ltd., Real Food Blends, Ajinomoto Cambrooke Inc., Otsuka Pharmaceutical Co. Ltd., Medtrition Inc., Nutri-Force Nutrition, Global Health Product Inc., VICTUS, Kate Farms, Baxter International Inc., Perrigo Nutritionals LLC, Reckitt Benckiser Group plc, Bio-Serv Inc., Nutrabalace Ltd., Med-Diet Laboratories Inc., Precision Foods-Kent Corporation, SimplyThick LLC, Vitaflow LLC .
request a sample hereMajor trend in this market includes: The Rise Of Advanced Feeding Pumps. For further insights on this market.
request a sample hereNorth America was the largest region in the enteral feeding formula market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enteral feeding formula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here